 |
市場調査レポート
商品コード
1455151
DNAポリメラーゼの世界市場規模、シェア、成長分析、タイプ別、用途別 - 産業予測、2024年～2031年Global DNA Polymerase Market Size, Share, Growth Analysis, By Type(Taq Polymerase, Pfu Polymerase), By Application(Polymerase Chain Reaction, DNA Sequencing) - Industry Forecast 2024-2031 |
||||||
| DNAポリメラーゼの世界市場規模、シェア、成長分析、タイプ別、用途別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
DNAポリメラーゼの世界市場規模は2022年に1億3,260万米ドルと評価され、予測期間（2024年～2031年）のCAGRは1.30%で、2023年の1億3,432万米ドルから2031年には1億4,895万米ドルに成長する見通しです。
世界のDNAポリメラーゼ市場は顕著な成長を遂げており、今後数年でさらに拡大すると予測されています。DNAポリメラーゼは、バイオテクノロジー、研究所、医療診断、法医学など、さまざまな領域で極めて重要な役割を果たしています。市場の成長軌道を後押ししている主な要因は、慢性疾患の蔓延の深刻化、遺伝子研究の進歩、個別化医療に対する需要の高まりなどです。成長の主な原動力のひとつは、遺伝子疾患や、がん、糖尿病、心血管疾患などの慢性疾患の罹患率の増加です。これらの疾患が世界的に増加し続ける中、DNAポリメラーゼの需要もDNA複製、増幅、塩基配列決定などの作業に対して高まっています。もう一つの大きな成長要因は、個別化医療の分野が急成長していることです。DNAポリメラーゼは、遺伝子の変異、突然変異、特定の疾患に関連するバイオマーカーの同定に役立っています。これにより、個々の患者を対象とした標的療法やカスタマイズされた治療レジメンが容易になり、臨床転帰が向上します。とはいえ、世界のDNAポリメラーゼ市場には課題もあります。その一つは、DNAポリメラーゼ、特にハイフィデリティーで特殊な酵素のコストが高いことです。これらの酵素は高価であるため、特に小規模の研究所や限られた予算で運営されている医療施設では、その利用が制限される可能性があります。さらに、市場競争は激しく、数多くの企業が多様なDNAポリメラーゼ製品を提供しています。このため市場参入企業間の競争は激化し、価格圧力につながり、小規模な企業が大きな市場シェアを獲得することは難しくなっています。さらに、特に医療診断や治療用途では、厳しい規制要件が市場参加者にハードルを突きつけています。規制基準の遵守と必要な承認の確保には時間とコストがかかり、状況をさらに複雑にしています。こうした課題にもかかわらず、世界のDNAポリメラーゼ市場は成長軌道を維持する構えです。技術の進歩、研究開発への投資の増加、DNAポリメラーゼの用途拡大が、当面の市場成長を促進すると予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
DNAポリメラーゼの世界市場：タイプ別
- 市場概要
- Taqポリメラーゼ
- Pfuポリメラーゼ
- 独自の酵素ブレンド
DNAポリメラーゼの世界市場：用途別
- 市場概要
- ポリメラーゼ連鎖反応
- DNA配列決定
- DNAクローニング
- SNP分析
- 次世代シーケンス
DNAポリメラーゼの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Thermo Fisher Scientific Inc.-United States
- Merck KGaA-Germany
- New England Biolabs-United States
- Promega Corporation-United States
- Agilent Technologies Inc.-United States
- Illumina, Inc.-United States
- QIAGEN N.V.-Netherlands
- Takara Bio Inc.-Japan
- Bio-Rad Laboratories, Inc.-United States
- F. Hoffmann-La Roche Ltd.-Switzerland
- Sigma-Aldrich Corporation（now part of Merck KGaA）-United States
- LGC Limited-United Kingdom
- Enzo Biochem, Inc.-United States
- Lucigen Corporation-United States
- Bioline GmbH（a Meridian Bioscience Company）-Germany
- Toyobo Co., Ltd.-Japan
- Genesee Scientific Corporation-United States
- Vazyme Biotech Co., Ltd.-China
- Takara Bio USA Holdings, Inc.-United States
- Jena Bioscience GmbH-Germany
Global DNA Polymerase Market size was valued at USD 132.6 million in 2022 and is poised to grow from USD 134.32 million in 2023 to USD 148.95 million by 2031, at a CAGR of 1.30% during the forecast period (2024-2031).
The global DNA polymerase market is experiencing notable growth and is anticipated to further expand in the forthcoming years. DNA polymerases play a pivotal role across various domains, encompassing biotechnology, research laboratories, medical diagnostics, and forensics. The market's upward trajectory is chiefly propelled by several factors, including the escalating prevalence of chronic diseases, advancements in genetic research, and the growing demand for personalized medicine. One of the primary drivers of growth is the increasing incidence of genetic disorders and chronic ailments such as cancer, diabetes, and cardiovascular diseases. As these conditions continue to rise globally, the demand for DNA polymerases for tasks like DNA replication, amplification, and sequencing also escalates. Another significant growth catalyst is the burgeoning field of personalized medicine. DNA polymerases are instrumental in identifying genetic variations, mutations, and biomarkers linked to specific diseases. This facilitates targeted therapies and customized treatment regimens for individual patients, resulting in enhanced clinical outcomes. Nevertheless, the global DNA polymerase market encounters certain challenges. One such obstacle is the high cost associated with DNA polymerases, particularly high-fidelity and specialized enzymes. The expense of these enzymes may restrict their accessibility, especially for smaller research laboratories and medical facilities operating with limited budgets. Moreover, the market is highly competitive, with numerous players offering a diverse array of DNA polymerase products. This intensifies competition among market participants, leading to pricing pressures and making it difficult for smaller entities to gain significant market share. Additionally, stringent regulatory requirements, particularly in medical diagnostics and therapeutic applications, pose hurdles for market players. Compliance with regulatory standards and securing necessary approvals can be time-consuming and costly, further complicating the landscape. Despite these challenges, the global DNA polymerase market is poised to sustain its growth trajectory. Technological advancements, heightened investments in research and development activities, and the expanding applications of DNA polymerases are anticipated to propel market growth in the foreseeable future.
Top-down and bottom-up approaches were used to estimate and validate the size of the global DNA polymerase market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global DNA Polymerase Market Segmental Analysis
Global DNA polymerase market is segmented based on type, application, and region. By type, the market is segmented into taq polymerase, pfu polymerase, and proprietary enzyme blends. By application, the market is segmented into polymerase chain reaction, DNA sequencing, DNA cloning, SNP analysis, next generation sequencing. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global DNA Polymerase Market
The surge in chronic diseases such as cancer and cardiovascular ailments has spurred an increased demand for diagnostic and treatment technologies. Consequently, in the post-COVID era, there has been a notable rise in the requirement for DNA polymerase, which plays a pivotal role in the amplification process of PCR (Polymerase Chain Reaction). Specifically, the treatment of cancer has witnessed heightened utilization of high-fidelity DNA polymerases. This has underscored the necessity for an advanced DNA polymerase capable of accurately replicating DNA and detecting mutations with a high degree of sensitivity and specificity. As a result, there has been a development of new DNA polymerase products with enhanced fidelity, speed, and overall performance. Moreover, specialized polymerases adept at amplifying and identifying DNA sequences associated with various diseases have also been introduced to the market.
Restraints in the Global DNA Polymerase Market
The rising cost of DNA polymerases presents a significant hurdle to the growth of the DNA polymerase market, hindering the adoption of innovative technologies that depend on costly enzymes. The developments in biotechnology have significantly impacted the pricing of DNA polymerases, leading to a steep increase in their costs. Consequently, some research laboratories or medical facilities may encounter challenges in affording these expensive polymerases.
Market Trends of the Global DNA Polymerase Market
With the increasing prominence of precision medicine, DNA polymerases are being employed to pinpoint specific genetic variations and mutations linked to diseases. This facilitates the creation of personalized treatments and therapies tailored to individual patients, thereby enhancing clinical outcomes.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global DNA Polymerase Market by Type
- Market Overview
- Taq Polymerase
- Pfu Polymerase
- and Proprietary Enzyme Blends
Global DNA Polymerase Market by Application
- Market Overview
- Polymerase Chain Reaction
- DNA Sequencing
- DNA Cloning
- SNP Analysis
- and Next Generation Sequencing
Global DNA Polymerase Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- New England Biolabs - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V. - Netherlands
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sigma-Aldrich Corporation (now part of Merck KGaA) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LGC Limited - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lucigen Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioline GmbH (a Meridian Bioscience Company) - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Toyobo Co., Ltd. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genesee Scientific Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vazyme Biotech Co., Ltd. - China
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio USA Holdings, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jena Bioscience GmbH - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
